GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
0 hedge funds and large institutions have $0 invested in GenMark Diagnostics, Inc in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 163 closing their positions.
100% less funds holding
Funds holding: 164 → 0 (-164)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1.62B → $0 (-$1.62B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 163
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$176M |
| 2 |
BlackRock
New York
|
-$142M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$104M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$87.7M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$85.8M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ADIM
151
Alpha DNA Investment Management
Columbia,
Maryland
| – | -$7K | -328 | Closed |
|
|
CFGS
152
Concourse Financial Group Securities
Birmingham,
Alabama
| – | -$7K | -275 | Closed |
|
153
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$4K | -200 | Closed |
|
154
US Bancorp
Minneapolis,
Minnesota
| – | -$4K | -185 | Closed |
|
|
TWA
155
TCI Wealth Advisors
Tucson,
Arizona
| – | -$4K | -171 | Closed |
|
|
APA
156
American Portfolios Advisors
Holbrook,
New York
| – | -$3.58K | -150 | Closed |
|
|
GWS
157
Glassman Wealth Services
Vienna,
Virginia
| – | -$3K | -116 | Closed |
|
|
EW
158
Evoke Wealth
Los Angeles,
California
| – | -$2K | -94 | Closed |
|
|
TFO
159
Tarbox Family Office
Newport Beach,
California
| – | -$2K | -69 | Closed |
|
|
QCG
160
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$1K | -54 | Closed |
|
|
RE
161
RBC Europe
London,
United Kingdom
| – | -$1.2K | -50 | Closed |
|
|
WCM
162
Wealthcare Capital Management
Richmond,
Virginia
| – | -$1K | -43 | Closed |
|
|
PCA
163
Providence Capital Advisors
Charlotte,
North Carolina
| – | -$1K | -40 | Closed |
|
GNMK Hedge Fund Activity: Q2 2021 in Review
0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2021, worth a combined $0 — down 100% from $1.62B a quarter earlier.
Sellers outnumbered buyers: 163 funds closed out of GNMK and 0 opened new positions — a net loss of 163 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Wasatch Advisors, exiting entirely with an estimated $176M sold.
- 0 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2021, down from 164 in Q1 2021.
- Funds reported $0 of GenMark Diagnostics, Inc stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new GenMark Diagnostics, Inc positions in Q2 2021 and 163 closed out, a net change of -163 holders.
- The largest GenMark Diagnostics, Inc seller in Q2 2021 was Wasatch Advisors, an estimated $176M sold.
Based on aggregated 13F filings for Q2 2021.